Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
| Autor: | Izikson, Ruvim *, Brune, Daniel, Bolduc, Jean-Sébastien, Bourron, Pierre, Fournier, Marion, Moore, Tamala Mallett, Pandey, Aseem, Perez, Lucia, Sater, Nessryne, Shrestha, Anju, Wague, Sophie, Samson, Sandrine I |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine April 2022 10(4):392-402 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|